Menetelmä solujen eristämiseksi ja menetelmällä eristetty solupopulaatio
The present invention is directed to a method for the isolation of a cell population from a sample of human umbilical cord blood comprising steps of contacting said sample with an antibody binding to core-2 type O-glycan, with a sialyl Lewis x (s Lex) and Neu5Aca2- 3Galß1-3(Neu5Aca2-3Galß1-4Glc NAcß...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | fin ; swe |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention is directed to a method for the isolation of a cell population from a sample of human umbilical cord blood comprising steps of contacting said sample with an antibody binding to core-2 type O-glycan, with a sialyl Lewis x (s Lex) and Neu5Aca2- 3Galß1-3(Neu5Aca2-3Galß1-4Glc NAcß1-6)Gal NAca epitopes, such as CHO-131, and isolating the cells bound to said antibody. The invention also provides compositions comprising human cells isolated from umbilical cord blood. |
---|